Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery [Phase 2]
Phase 2 clinical trial evaluating Bevacizumab plus Letrozole for postmenopausal women with locally advanced or metastatic breast cancer not …
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients [EARLY_Phase 1]
Early-phase trial investigates FACBC PET and PEM as staging tools and indicators of therapeutic response in breast cancer.
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: The CEASE Study: Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast Cancer [NA]
The CEASE study, conducted by George Washington University, evaluated a computer-based educational module to reduce arthralgia syndrome asso…
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone: A Whole Body MRI Study [NA]
This document provides an update on a clinical trial evaluating the response of metastatic breast cancer to cancer therapies in bone. The as…
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: Neoadjuvant Chemotherapy of 6 Cycles vs 8 Cycles in Node Positve Breast Cancer [Phase 3]
A Phase 3 trial comparing six versus eight cycles of neoadjuvant chemotherapy for node-positive breast cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: Neoadjuvant Combined Endocrine and HER2 Target Therapy in Postmenopausal Women With ER and Her2 Positive Breast Cancer [Phase 2]
The Phase 2 neoadjuvant trial NCT01275859 evaluating combined endocrine and HER2-targeted therapy in postmenopausal women with ER-positive a…
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms [Phase 3]
Phase 3 trial evaluating prasterone (dehydroepiandrosterone) for vaginal symptoms in postmenopausal cancer survivors has completed with resu…
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer [Phase 3]
A Phase 3 trial compares simultaneous versus sequential use of adjuvant chemotherapy and GnRH agonist therapy in ER-positive, premenopausal …
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer [Phase 1]
Phase 1 study evaluating the AKT inhibitor MK-2206 in combination with Paclitaxel for locally advanced or metastatic solid tumors and metast…
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394) [Phase 3]
Phase III trial comparing adjuvant high-dose cyclophosphamide plus doxorubicin (AC) versus sequential doxorubicin followed by cyclophosphami…
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6
A pilot study evaluating varying doses of tamoxifen in breast cancer patients with respect to CYP2D6 genetic polymorphisms.
-
CLINICAL_TRIALS trial_result · 2017-08-24Clinical Trial Update: Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases [Phase 3]
Phase 3 trial evaluating stereotactic radiation therapy with or without whole-brain radiation therapy for brain metastases; completed with r…
-
CLINICAL_TRIALS trial_result · 2017-08-24Clinical Trial Update: Intra-operative Digital vs. Standard Mammography [Phase 4]
Phase 4 trial comparing intra-operative digital mammography to standard mammography in breast cancer has completed, with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: Assessment of TK006 in Patients With Breast Cancer-related Bone Metastases [Phase 1]
Phase 1 trial update for TK006 in breast cancer with bone metastases; the trial status is currently unknown.
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer [Phase 2]
Phase 2 trial update on neoadjuvant carboplatin with weekly Abraxane and trastuzumab in HER2-positive breast cancer.
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: Effect of a Tailored Program of Physical Activity and Nutritional Counseling on Fatigue Reduction in Breast Cancer Patients Receiving an Adjuvant Treatment [Phase 3]
A Phase 3 trial evaluated whether a tailored program of physical activity and nutritional counseling reduces fatigue in breast cancer patien…
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: Identification and Evaluation of Biomarkers of Resistance to Neoadjuvant Chemotherapy (IDEA SEIN) [NA]
This clinical trial update describes the IDEA SEIN study, which aims to identify and evaluate biomarkers of resistance to neoadjuvant chemot…
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: Breast-Conserving Surgery Techniques in Treating Women With Breast Cancer [Phase 2]
An update on a Phase 2 clinical trial evaluating breast-conserving surgery techniques for women with breast cancer; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy [Phase 3]
Phase 3 randomized, placebo-controlled trial evaluating glutamine for peripheral neuropathy in breast cancer patients; the study has complet…
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Preventing Sexual Dysfunction With Aromatase Inhibitors [Phase 2]
A Phase 2 clinical trial at MD Anderson explored preventing sexual dysfunction in patients receiving aromatase inhibitors for breast cancer;…
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
This study reports on quality of life, employment, and informal caregiver costs for women undergoing chemotherapy for breast cancer.
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer [Phase 2]
Phase 2 trial evaluating metformin to reduce paclitaxel-related neuropathy in breast cancer; the study was terminated and results were poste…
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer [Phase 1]
This Phase 1 trial update reports results for a NY-ESO-1 vaccine with the GLA-SE adjuvant in patients with unresectable or metastatic cancer…
-
CLINICAL_TRIALS trial_result · 2017-08-16Clinical Trial Update: Paclitaxel and Capecitabine in Treating Women With Metastatic Breast Cancer [Phase 2]
Phase 2 trial results evaluate the combination of paclitaxel and capecitabine in women with metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2017-08-16Clinical Trial Update: Flaxseed, Aromatase Inhibitors and Breast Tumor Characteristics [NA]
A completed trial evaluated flaxseed in combination with aromatase inhibitors and its effect on breast tumor characteristics. The results we…